Σούπος Νικόλαος

Πτυχίο Ιατρικής

Παθολογική Ογκολογία 

• Aγγλικά
• Ιταλικά

Anti-PD1/PDL1 induced psoriasis.

Voudouri D, Nikolaou V, Laschos K, Charpidou A, Soupos N, Triantafyllopoulou I, Panoutsopoulou I, Aravantinos G, Syrigos K, Stratigos A.Curr Probl Cancer. 2017 Nov-Dec;41(6):407-412. doi: 10.1016/j.currproblcancer.2017.10.003. Epub 2017 Oct 18

Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?

Lampropoulou DI, Laschos K, Amylidi AL, Angelaki A, Soupos N, Boumpoucheropoulos S, Papadopoulou E, Nanou E, Zidianakis V, Nasioulas G, Fildissis G, Aravantinos G.J Oncol Pharm Pract. 2020 Apr;26(3):747-753. doi: 10.1177/1078155219865597. Epub 2019 Aug 5
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.

Sollena P, Nikolaou V, Soupos N, Kotteas E, Voudouri D, Stratigos AJ, Fattore D, Annunziata MC, Orlandi A, Di Nardo L, Apalla Z, Deilhes F, Romano MC, Fabbrocini G, Sibaud V, Peris K; European Network for Cutaneous ADverse event of Oncologic drugs (ENCADO) group.Breast Cancer Res Treat. 2021 Jan;185(1):247-253. doi: 10.1007/s10549-020-05914-w. Epub 2020 Sep 10.

Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.

Nikitas N, Karadimou A, Tsitoura E, Soupos N, Tsiatas M, Karavasilis V, Pectasides D, Pavlidis N, Chrisofos M, Adamakis I, Murray S, Fountzilas G, Dimopoulos MA, Bamias A.

Pharmacogenomics. 2012 Nov;13(14):1595-607. doi: 10.2217/pgs.12.162.

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.

Pliarchopoulou K, Kalogeras KT, Kronenwett R, Wirtz RM, Eleftheraki AG, Batistatou A, Bobos M, Soupos N, Polychronidou G, Gogas H, Samantas E, Christodoulou C, Makatsoris T, Pavlidis N, Pectasides D, Fountzilas G.

Cancer Chemother Pharmacol. 2013 Jan;71(1):245-55. doi: 10.1007/s00280-012-2002-z. Epub 2012 Oct 25.

Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.

Korantzis I, Kalogeras KT, Papaxoinis G, Kotoula V, Koutras A, Soupos N, Papakostas P, Dionysopoulos D, Samantas E, Christodoulou C, Linardou H, Pectasides D, Fountzilas G.

Anticancer Res. 2012 Oct;32(10):4569-80.

The mediating effect of Mediterranean diet on the relation between smoking and colorectal cancer: a case-control study.

Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E, Xinopoulos D, Linos A, Panagiotakos DB.

Eur J Public Health. 2012 Aug 20. [Epub ahead of print]

The role of number of meals, coffee intake, salt and type of cookware on colorectal cancer development in the context of the Mediterranean diet.

Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E, Linos A, Xinopoulos D, Panagiotakos DB.

Public Health Nutr. 2012 Aug 8:1-8. [Epub ahead of print]

Alcohol consumption and colorectal cancer in a Mediterranean population: a case-control study.

Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E, Xinopoulos D, Linos A, Panagiotakos D.

Dis Colon Rectum. 2012 Jun;55(6):703-10. doi: 10.1097/DCR.0b013e31824e612a.

Synchronous Gastric Adenocarcinoma and Diffuse Large B-Cell Lymphoma in the Pelvis: A Rare Case Presentation.

Pliakou E, Lampropoulou DI, Soupos N, Aravantinos G.Case Rep Gastrointest Med. 2022 Apr 28;2022:7535036. doi: 10.1155/2022/7535036. eCollection 2022

Metabolic syndrome and colorectal cancer: the protective role of Mediterranean diet–a case-control study.

Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E, Xinopoulos D, Linos A, Panagiotakos DB.

Angiology. 2012 Jul;63(5):390-6. doi: 10.1177/0003319711421164. Epub 2012 Jan 20.

Metabolic syndrome and colorectal cancer: the protective role of Mediterranean diet–a case-control study.

Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E, Xinopoulos D, Linos A, Panagiotakos DB.

Angiology. 2012 Jul;63(5):390-6. doi: 10.1177/0003319711421164. Epub 2012 Jan 20.

A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.

Bamias A, Bamia C, Karadimou A, Soupos N, Zagouri F, Rodolakis A, Haidopoulos D, Vlahos G, Thomakos N, Antsaklis A, Dimopoulos MA.

Oncology. 2011;81(5-6):365-71. doi: 10.1159/000334230. Epub 2012 Jan 13.

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

Fountzilas G, Valavanis C, Kotoula V, Eleftheraki AG, Kalogeras KT, Tzaida O, Batistatou A, Kronenwett R, Wirtz RM, Bobos M, Timotheadou E, Soupos N, Pentheroudakis G, Gogas H, Vlachodimitropoulos D, Polychronidou G, Aravantinos G, Koutras A, Christodoulou C, Pectasides D, Arapantoni P.

J Transl Med. 2012 Jan 12;10:10. doi: 10.1186/1479-5876-10-10.

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.

Bamias A, Karadimou A, Soupos N, Sotiropoulou M, Zagouri F, Haidopoulos D, Thomakos N, Rodolakis A, Antsaklis A, Dimopoulos MA.

Gynecol Oncol. 2011 Oct;123(1):37-42. doi: 10.1016/j.ygyno.2011.06.033. Epub 2011 Jul 18.

Discriminating ability of the MedDietScore in relation to gastrointestinal tract cancer: A sensitivity-specificity analysis.

Kontou N, Panagiotakos DB, Psaltopoulou T, Soupos N, Polychronopoulos E, Linos A, Paraskevas E.

Agro Food Hi-Tech 2011;

Τμήμα

• Παθολογικό-Ογκολογικό

Επικοινωνία

Ευρωκλινική Αθηνών

Αθανασιάδου 7-9,  Αθήνα, ΤΚ 115 21

Τηλέφωνο: 210 6416658

Τηλέφωνο για ραντεβού: 210 6416655

Φαξ: 210 6416555